IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion

Published:2019-07-15 Issue:8 Volume:129 Page:3324-3338
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Chan Li-Chuan^ORCID,Li Chia-Wei,Xia Weiya,Hsu Jung-Mao,Lee Heng-Huan^ORCID,Cha Jong-Ho,Wang Hung-Ling,Yang Wen-Hao^ORCID,Yen Er-Yen^ORCID,Chang Wei-Chao,Zha Zhengyu,Lim Seung-Oe,Lai Yun-Ju,Liu Chunxiao,Liu Jielin,Dong Qiongzhu,Yang Yi^ORCID,Sun Linlin,Wei Yongkun,Nie Lei,Hsu Jennifer L.,Li Hui,Ye Qinghai,Hassan Manal M.,Amin Hesham M.,Kaseb Ahmed O.,Lin Xin^ORCID,Wang Shao-Chun^ORCID,Hung Mien-Chie

Funder

National Institutes of Health

Cancer Prevention & Research Institute of Texas

Ministry of Health and Welfare

Ministry of Science and Technology, Taiwan

National Research Foundation of Korea

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/126022/files/pdf

Reference52 articles.

1. Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

2. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

3. Combination cancer immunotherapy and new immunomodulatory targets

4. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

5. The tumour glyco-code as a novel immune checkpoint for immunotherapy

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway;Journal of Ethnopharmacology;2024-03

2. Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance;Autophagy;2024-01-04

3. Biology-driven therapy advances in high-grade serous ovarian cancer;Journal of Clinical Investigation;2024-01-02

4. The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells;Chinese Journal of Traumatology;2024-01

5. Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-α signaling axis in triple-negative breast cancer;Cancer Letters;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3